Perioperative Keytruda (pembrolizumab) plus enfortumab vedotin improved survival in cisplatin-ineligible muscle-invasive ...

Robert Yu once wanted to be an actor. He became a pharmaceutical executive, but the camera never lost its appeal. Now, the ...

IQVIA Korea posted revenue of 196.11 billion won ($144.77 million) in 2025, up 190 percent from 67.62 billion won in 2015, ...

Large health insurance arrears among self-employed subscribers more than doubled over four years, even as total overdue ...

Samsung Bioepis said Friday that it has partnered with Teva Pharmaceutical Industries to develop and commercialize two ...

Drug utilization review (DUR) checks for obesity drug Mounjaro reached 2.64 million in the year following its Korean launch, ...

Severance Cardiovascular Hospital has performed 10,000 atrial fibrillation ablation procedures, becoming the first single ...

Huons will unveil preclinical data on investigational gastrointestinal and oral obesity drug candidates at two global ...

Professor Oh Joo-han of the Department of Orthopedic Surgery at Seoul National University Bundang Hospital (SNUBH) has been ...

Chronic obstructive pulmonary disease (COPD) patients who struggle to inhale strongly enough to use dry-powder inhalers (DPIs ...

Humedix will invest about 3.3 billion won ($2.4 million) in research and development through 2029 after being selected for a government program supporting companies with global growth potential.The ae ...

Korea's national health insurance system spent 394.1 billion won ($289 million) on care for type 2 diabetes patients with ...